Last reviewed · How we verify
NCT04310839: COATI
Outpatient Left Laparoscopic Colectomy
trial testing Colectomy in Colonic Neoplasms in 30 participants. Completed in 2 December 2022.
2 November 2022
Quick facts
| Lead sponsor | Groupe Hospitalier de la Rochelle Ré Aunis |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 3 November 2020 |
| Primary completion | 2 November 2022 |
| Estimated completion | 2 December 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Colectomy
Conditions studied
- Colonic Neoplasms — all drugs for Colonic Neoplasms →
- Colonic Diverticulosis — all drugs for Colonic Diverticulosis →
Sponsor
Groupe Hospitalier de la Rochelle Ré Aunis
Who can join
18 and older, any sex, with Colonic Neoplasms or Colonic Diverticulosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The success of the enhanced recovery program after surgery leads us to consider outpatient management of the colectomy. To this end, the investigators have designed an observational and prospective study of left laparoscopic colectomy on an outpatient basis. The objective is to assess the harmlessness of this management compared to standard management in the context of a public hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04310839
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Colectomy
Trials testing the same drug.
- NCT06124378 — Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer · Phase 2 · active not recruiting
- NCT05424939 — Management of Obstructive Colon Tumors in Istanbul · unknown
- NCT06300541 — Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease · recruiting
- NCT01536535 — Predicting Response to Standardized Pediatric Colitis Therapy · Phase 4 · completed
Other recruiting trials for Colonic Neoplasms
Currently open trials in the same condition.
- NCT07173985 — Strategies for Optimizing a Mailed FIT Program in Appalachia · NA · recruiting
- NCT06885697 — Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi · Phase 1 · recruiting
- NCT06371898 — Comparison of MORbidity of Submucosal DIssection Resection of Giant cOlon Lesions Versus Surgery: a National Multicenter · active not recruiting
- NCT06119867 — CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE) · Phase 3 · recruiting
- NCT06124378 — Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer · Phase 2 · active not recruiting
Other Groupe Hospitalier de la Rochelle Ré Aunis trials
Trials by the same sponsor.
- NCT06884397 — Use of Artificial Intelligence to Predict Complications Following Abdominal Aortic Surgery · recruiting
- NCT06742671 — Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis · recruiting
- NCT05418699 — Real-life Data From Diabetic Patients on Closed-loop Pumps · completed
- NCT04184375 — Cognitive Stimulation for Elderly Bipolar Patients · NA · recruiting
- NCT04610281 — The Inner Garden and Care for Children With Moderate to Severe Agitation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04310839 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Groupe Hospitalier de la Rochelle Ré Aunis
- Last refreshed: 9 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04310839.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing